25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MOREPEN LABORATORIES LTD.
Buy, Hold or Sell?

Let's analyze Morepen together

I guess you are interested in MOREPEN LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MOREPEN LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about MOREPEN LABORATORIES LTD.

I send you an email if I find something interesting about MOREPEN LABORATORIES LTD..

1. Quick Overview

1.1. Quick analysis of Morepen (30 sec.)










1.2. What can you expect buying and holding a share of Morepen? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
INR15.46
Expected worth in 1 year
INR22.38
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR6.92
Return On Investment
7.8%

For what price can you sell your share?

Current Price per Share
INR88.37
Expected price per share
INR72.73 - INR100.80
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Morepen (5 min.)




Live pricePrice per Share (EOD)
INR88.37
Intrinsic Value Per Share
INR-16.23 - INR-10.49
Total Value Per Share
INR-0.77 - INR4.98

2.2. Growth of Morepen (5 min.)




Is Morepen growing?

Current yearPrevious yearGrowGrow %
How rich?$99.9m$88.7m$11.1m11.2%

How much money is Morepen making?

Current yearPrevious yearGrowGrow %
Making money$11.3m$4.5m$6.7m59.8%
Net Profit Margin5.7%2.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Morepen (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Morepen?

Welcome investor! Morepen's management wants to use your money to grow the business. In return you get a share of Morepen.

First you should know what it really means to hold a share of Morepen. And how you can make/lose money.

Speculation

The Price per Share of Morepen is INR88.37. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Morepen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Morepen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR15.46. Based on the TTM, the Book Value Change Per Share is INR1.73 per quarter. Based on the YOY, the Book Value Change Per Share is INR3.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Morepen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.020.0%0.020.0%0.010.0%0.020.0%0.010.0%
Usd Book Value Change Per Share0.020.0%0.020.0%0.040.0%0.030.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.0%0.020.0%0.040.0%0.030.0%0.030.0%
Usd Price Per Share0.50-0.50-0.30-0.34-0.32-
Price to Earnings Ratio23.97-23.97-36.38-22.76-24.43-
Price-to-Total Gains Ratio24.32-24.32-8.07-14.90-13.04-
Price to Book Ratio2.72-2.72-1.87-2.81-2.97-
Price-to-Total Gains Ratio24.32-24.32-8.07-14.90-13.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.042766
Number of shares958
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.020.03
Gains per Quarter (958 shares)19.5524.57
Gains per Year (958 shares)78.2198.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10786809888
201561460196186
302352240294284
403133021393382
503913801491480
604694581589578
705475361687676
806266141785774
907046921883872
1007827702981970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%3.00.03.050.0%3.00.03.050.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of MOREPEN LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.7301.7300%3.182-46%2.170-20%2.577-33%
Book Value Per Share--15.46215.4620%13.732+13%10.532+47%9.545+62%
Current Ratio--2.2112.2110%2.354-6%1.708+29%1.570+41%
Debt To Asset Ratio--0.3450.3450%0.322+7%0.441-22%0.466-26%
Debt To Equity Ratio--0.5260.5260%0.476+11%0.842-37%0.941-44%
Dividend Per Share----0%-0%0.004-100%0.004-100%
Enterprise Value--18587155567.04018587155567.0400%10490984309.120+77%11784143656.704+58%10791241251.253+72%
Eps--1.7551.7550%0.706+149%1.340+31%1.205+46%
Ev To Ebitda Ratio--infinfnan%12.246+inf%infnan%infnan%
Ev To Sales Ratio--1.1001.1000%0.740+49%0.824+33%0.815+35%
Free Cash Flow Per Share---0.145-0.1450%-2.503+1623%-0.970+568%-0.792+445%
Free Cash Flow To Equity Per Share---0.145-0.1450%0.117-224%-0.012-92%0.006-2642%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---10.486--------
Intrinsic Value_10Y_min---16.234--------
Intrinsic Value_1Y_max---0.990--------
Intrinsic Value_1Y_min---1.656--------
Intrinsic Value_3Y_max---3.021--------
Intrinsic Value_3Y_min---4.980--------
Intrinsic Value_5Y_max---5.107--------
Intrinsic Value_5Y_min---8.283--------
Market Cap48422693566.080+52%23046944567.04023046944567.0400%14071458309.120+64%16003544056.704+44%14911654417.920+55%
Net Profit Margin--0.0570.0570%0.027+108%0.055+4%0.052+10%
Operating Margin----0%0.040-100%0.049-100%0.047-100%
Operating Ratio--1.5541.5540%1.638-5%1.607-3%1.610-3%
Pb Ratio5.715+52%2.7202.7200%1.870+45%2.811-3%2.966-8%
Pe Ratio50.356+52%23.96723.9670%36.384-34%22.757+5%24.425-2%
Price Per Share88.370+52%42.06042.0600%25.680+64%29.206+44%27.213+55%
Price To Free Cash Flow Ratio-608.257-110%-289.502-289.5020%-10.260-96%-46.650-84%-10.401-96%
Price To Total Gains Ratio51.090+52%24.31724.3170%8.071+201%14.904+63%13.043+86%
Quick Ratio--0.9310.9310%0.945-1%0.682+36%0.638+46%
Return On Assets--0.0740.0740%0.035+114%0.074+1%0.069+8%
Return On Equity--0.1130.1130%0.051+121%0.137-17%0.134-15%
Total Gains Per Share--1.7301.7300%3.182-46%2.174-20%2.581-33%
Usd Book Value--99972691.60099972691.6000%88788828.600+13%68101637.360+47%61719748.567+62%
Usd Book Value Change Per Share--0.0200.0200%0.038-46%0.026-20%0.030-33%
Usd Book Value Per Share--0.1820.1820%0.162+13%0.124+47%0.113+62%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Enterprise Value--219328435.691219328435.6910%123793614.848+77%139052895.149+58%127336646.765+72%
Usd Eps--0.0210.0210%0.008+149%0.016+31%0.014+46%
Usd Free Cash Flow---939386.200-939386.2000%-16182826.800+1623%-6274097.760+568%-5119605.033+445%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.030+1623%-0.011+568%-0.009+445%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%0.001-224%0.000-92%0.000-2642%
Usd Market Cap571387784.080+52%271953945.891271953945.8910%166043208.048+64%188841819.869+44%175957522.131+55%
Usd Price Per Share1.043+52%0.4960.4960%0.303+64%0.345+44%0.321+55%
Usd Profit--11346868.20011346868.2000%4563673.600+149%8665516.440+31%7788633.267+46%
Usd Revenue--199471035.000199471035.0000%167268540.000+19%157282138.640+27%145940665.400+37%
Usd Total Gains Per Share--0.0200.0200%0.038-46%0.026-20%0.030-33%
 EOD+5 -3MRQTTM+0 -0YOY+24 -135Y+26 -1210Y+27 -11

3.3 Fundamental Score

Let's check the fundamental score of MOREPEN LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1550.356
Price to Book Ratio (EOD)Between0-15.715
Net Profit Margin (MRQ)Greater than00.057
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.931
Current Ratio (MRQ)Greater than12.211
Debt to Asset Ratio (MRQ)Less than10.345
Debt to Equity Ratio (MRQ)Less than10.526
Return on Equity (MRQ)Greater than0.150.113
Return on Assets (MRQ)Greater than0.050.074
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of MOREPEN LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.188
Ma 20Greater thanMa 5079.943
Ma 50Greater thanMa 10081.681
Ma 100Greater thanMa 20078.343
OpenGreater thanClose85.880
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About MOREPEN LABORATORIES LTD.

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2024-12-08 14:03:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Morepen earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 5.7% means that ₹0.06 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 5.7%. The company is making a profit. +1
  • The TTM is 5.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.7%TTM5.7%0.0%
TTM5.7%YOY2.7%+3.0%
TTM5.7%5Y5.5%+0.2%
5Y5.5%10Y5.2%+0.3%
4.3.1.2. Return on Assets

Shows how efficient Morepen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.4% Return on Assets means that Morepen generated ₹0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 7.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.4%TTM7.4%0.0%
TTM7.4%YOY3.5%+4.0%
TTM7.4%5Y7.4%+0.1%
5Y7.4%10Y6.9%+0.4%
4.3.1.3. Return on Equity

Shows how efficient Morepen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.3% Return on Equity means Morepen generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 11.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.3%TTM11.3%0.0%
TTM11.3%YOY5.1%+6.2%
TTM11.3%5Y13.7%-2.4%
5Y13.7%10Y13.4%+0.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of MOREPEN LABORATORIES LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Morepen is operating .

  • Measures how much profit Morepen makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.0%-4.0%
TTM-5Y4.9%-4.9%
5Y4.9%10Y4.7%+0.1%
4.3.2.2. Operating Ratio

Measures how efficient Morepen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.55 means that the operating costs are ₹1.55 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 1.554. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.554. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.554TTM1.5540.000
TTM1.554YOY1.638-0.083
TTM1.5545Y1.607-0.053
5Y1.60710Y1.610-0.003
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of MOREPEN LABORATORIES LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Morepen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.21 means the company has ₹2.21 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 2.211. The company is able to pay all its short-term debts. +1
  • The TTM is 2.211. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.211TTM2.2110.000
TTM2.211YOY2.354-0.143
TTM2.2115Y1.708+0.504
5Y1.70810Y1.570+0.137
4.4.3.2. Quick Ratio

Measures if Morepen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.93 means the company can pay off ₹0.93 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 0.931. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.931. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.931TTM0.9310.000
TTM0.931YOY0.945-0.013
TTM0.9315Y0.682+0.249
5Y0.68210Y0.638+0.044
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of MOREPEN LABORATORIES LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Morepen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Morepen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.34 means that Morepen assets are financed with 34.5% credit (debt) and the remaining percentage (100% - 34.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 0.345. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.345. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.345TTM0.3450.000
TTM0.345YOY0.322+0.022
TTM0.3455Y0.441-0.096
5Y0.44110Y0.466-0.025
4.5.4.2. Debt to Equity Ratio

Measures if Morepen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 52.6% means that company has ₹0.53 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MOREPEN LABORATORIES LTD.:

  • The MRQ is 0.526. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.526. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.526TTM0.5260.000
TTM0.526YOY0.476+0.051
TTM0.5265Y0.842-0.316
5Y0.84210Y0.941-0.098
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Morepen generates.

  • Above 15 is considered overpriced but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 23.97 means the investor is paying ₹23.97 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MOREPEN LABORATORIES LTD.:

  • The EOD is 50.356. Based on the earnings, the company is expensive. -2
  • The MRQ is 23.967. Based on the earnings, the company is fair priced.
  • The TTM is 23.967. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD50.356MRQ23.967+26.389
MRQ23.967TTM23.9670.000
TTM23.967YOY36.384-12.416
TTM23.9675Y22.757+1.210
5Y22.75710Y24.425-1.668
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MOREPEN LABORATORIES LTD.:

  • The EOD is -608.257. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -289.502. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -289.502. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-608.257MRQ-289.502-318.755
MRQ-289.502TTM-289.5020.000
TTM-289.502YOY-10.260-279.241
TTM-289.5025Y-46.650-242.852
5Y-46.65010Y-10.401-36.249
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Morepen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.72 means the investor is paying ₹2.72 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of MOREPEN LABORATORIES LTD.:

  • The EOD is 5.715. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.720. Based on the equity, the company is underpriced. +1
  • The TTM is 2.720. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.715MRQ2.720+2.995
MRQ2.720TTM2.7200.000
TTM2.720YOY1.870+0.850
TTM2.7205Y2.811-0.091
5Y2.81110Y2.966-0.155
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets12,932,051
Total Liabilities4,459,789
Total Stockholder Equity8,472,262
 As reported
Total Liabilities 4,459,789
Total Stockholder Equity+ 8,472,262
Total Assets = 12,932,051

Assets

Total Assets12,932,051
Total Current Assets8,890,440
Long-term Assets4,041,611
Total Current Assets
Cash And Cash Equivalents 169,451
Short-term Investments 495,530
Net Receivables 3,249,381
Inventory 2,485,942
Other Current Assets 2,487,893
Total Current Assets  (as reported)8,890,440
Total Current Assets  (calculated)8,888,197
+/- 2,243
Long-term Assets
Property Plant Equipment 2,376,559
Goodwill 744,742
Intangible Assets 196,682
Long-term Assets Other 638,844
Long-term Assets  (as reported)4,041,611
Long-term Assets  (calculated)3,956,827
+/- 84,784

Liabilities & Shareholders' Equity

Total Current Liabilities4,020,446
Long-term Liabilities439,343
Total Stockholder Equity8,472,262
Total Current Liabilities
Short Long Term Debt 256,352
Accounts payable 2,950,275
Other Current Liabilities 58,578
Total Current Liabilities  (as reported)4,020,446
Total Current Liabilities  (calculated)3,265,205
+/- 755,241
Long-term Liabilities
Long term Debt 33,640
Long-term Liabilities  (as reported)439,343
Long-term Liabilities  (calculated)33,640
+/- 405,703
Total Stockholder Equity
Total Stockholder Equity (as reported)8,472,262
Total Stockholder Equity (calculated)0
+/- 8,472,262
Other
Capital Stock1,022,271
Common Stock Shares Outstanding 511,169
Net Debt 120,541
Net Invested Capital 8,762,254
Net Working Capital 4,869,994
Property Plant and Equipment Gross 2,376,559



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
6,151,774
6,634,639
8,581,460
10,700,527
11,104,951
12,932,051
12,932,05111,104,95110,700,5278,581,4606,634,6396,151,77400
   > Total Current Assets 
1,919,455
2,434,400
2,994,684
3,721,765
5,267,910
7,343,011
7,561,647
8,890,440
8,890,4407,561,6477,343,0115,267,9103,721,7652,994,6842,434,4001,919,455
       Cash And Cash Equivalents 
0
0
95,951
136,391
413,869
158,026
216,658
169,451
169,451216,658158,026413,869136,39195,95100
       Short-term Investments 
0
0
225
0
270,893
352,309
401,524
495,530
495,530401,524352,309270,893022500
       Net Receivables 
1,019,064
1,271,460
1,410,874
1,376,805
1,819,842
2,506,431
2,632,470
3,249,381
3,249,3812,632,4702,506,4311,819,8421,376,8051,410,8741,271,4601,019,064
       Inventory 
646,649
768,869
942,016
1,384,757
1,753,257
2,758,541
2,288,863
2,485,942
2,485,9422,288,8632,758,5411,753,2571,384,757942,016768,869646,649
       Other Current Assets 
179,025
326,918
536,587
760,531
1,178,147
1,863,808
2,349,593
2,487,893
2,487,8932,349,5931,863,8081,178,147760,531536,587326,918179,025
   > Long-term Assets 
0
0
3,157,090
2,912,874
3,313,550
3,357,516
3,543,304
4,041,611
4,041,6113,543,3043,357,5163,313,5502,912,8743,157,09000
       Property Plant Equipment 
1,934,142
1,723,967
1,473,671
1,340,894
1,312,415
1,607,929
1,840,127
2,376,559
2,376,5591,840,1271,607,9291,312,4151,340,8941,473,6711,723,9671,934,142
       Goodwill 
0
0
744,798
744,742
744,742
744,742
744,742
744,742
744,742744,742744,742744,742744,742744,79800
       Intangible Assets 
0
0
146,159
80,616
210,188
309,338
254,986
196,682
196,682254,986309,338210,18880,616146,15900
       Long-term Assets Other 
0
0
0
-10
1,037,284
1
639,177
638,844
638,844639,17711,037,284-10000
> Total Liabilities 
0
0
3,625,477
3,798,662
4,338,555
4,919,522
3,580,474
4,459,789
4,459,7893,580,4744,919,5224,338,5553,798,6623,625,47700
   > Total Current Liabilities 
3,248,612
3,401,214
3,391,699
3,514,436
4,038,000
4,564,569
3,211,631
4,020,446
4,020,4463,211,6314,564,5694,038,0003,514,4363,391,6993,401,2143,248,612
       Short Long Term Debt 
0
0
101,147
125,435
162,174
172,479
242,306
256,352
256,352242,306172,479162,174125,435101,14700
       Accounts payable 
1,248,794
1,748,844
1,681,502
1,723,043
2,088,489
2,581,156
2,268,793
2,950,275
2,950,2752,268,7932,581,1562,088,4891,723,0431,681,5021,748,8441,248,794
       Other Current Liabilities 
136,170
225,996
261,690
314,120
388,564
457,045
450,096
58,578
58,578450,096457,045388,564314,120261,690225,996136,170
   > Long-term Liabilities 
0
0
233,778
284,226
300,555
354,953
368,843
439,343
439,343368,843354,953300,555284,226233,77800
> Total Stockholder Equity
0
0
2,530,928
2,840,611
4,247,498
5,785,612
7,529,081
8,472,262
8,472,2627,529,0815,785,6124,247,4982,840,6112,530,92800
   Common Stock
899,586
899,586
899,586
899,586
899,586
955,586
1,022,271
0
01,022,271955,586899,586899,586899,586899,586899,586
   Retained Earnings 
-1,344,515
-1,048,602
-760,109
-424,317
546,542
1,513,368
1,900,120
0
01,900,1201,513,368546,542-424,317-760,109-1,048,602-1,344,515
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
733,494
734,381
717,400
691,291
1,127,319
998,607
908,804
0
0908,804998,6071,127,319691,291717,400734,381733,494



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue16,904,325
Cost of Revenue-10,624,249
Gross Profit6,280,0766,280,076
 
Operating Income (+$)
Gross Profit6,280,076
Operating Expense-15,652,774
Operating Income1,251,551-9,372,698
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,099,789
Selling And Marketing Expenses0
Operating Expense15,652,7741,099,789
 
Net Interest Income (+$)
Interest Income0
Interest Expense-37,102
Other Finance Cost-0
Net Interest Income-37,102
 
Pretax Income (+$)
Operating Income1,251,551
Net Interest Income-37,102
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,354,1571,251,551
EBIT - interestExpense = -37,102
961,599
998,701
Interest Expense37,102
Earnings Before Interest and Taxes (EBIT)01,391,259
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,354,157
Tax Provision-387,954
Net Income From Continuing Ops966,203966,203
Net Income961,599
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net037,102
 

Technical Analysis of Morepen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Morepen. The general trend of Morepen is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Morepen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MOREPEN LABORATORIES LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 94.48 < 100.80.

The bearish price targets are: 87.32 > 72.79 > 72.73.

Tweet this
MOREPEN LABORATORIES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MOREPEN LABORATORIES LTD.. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MOREPEN LABORATORIES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MOREPEN LABORATORIES LTD.. The current macd is 2.03651221.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Morepen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Morepen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Morepen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MOREPEN LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartMOREPEN LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MOREPEN LABORATORIES LTD.. The current adx is 23.50.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Morepen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
MOREPEN LABORATORIES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MOREPEN LABORATORIES LTD.. The current sar is 79.70.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MOREPEN LABORATORIES LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MOREPEN LABORATORIES LTD.. The current rsi is 66.19. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
MOREPEN LABORATORIES LTD. Daily Relative Strength Index (RSI) ChartMOREPEN LABORATORIES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MOREPEN LABORATORIES LTD.. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Morepen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
MOREPEN LABORATORIES LTD. Daily Stochastic Oscillator ChartMOREPEN LABORATORIES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MOREPEN LABORATORIES LTD.. The current cci is 104.91.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
MOREPEN LABORATORIES LTD. Daily Commodity Channel Index (CCI) ChartMOREPEN LABORATORIES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MOREPEN LABORATORIES LTD.. The current cmo is 47.74.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
MOREPEN LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) ChartMOREPEN LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MOREPEN LABORATORIES LTD.. The current willr is -6.84340321.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
MOREPEN LABORATORIES LTD. Daily Williams %R ChartMOREPEN LABORATORIES LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MOREPEN LABORATORIES LTD..

MOREPEN LABORATORIES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MOREPEN LABORATORIES LTD.. The current atr is 3.28812987.

MOREPEN LABORATORIES LTD. Daily Average True Range (ATR) ChartMOREPEN LABORATORIES LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MOREPEN LABORATORIES LTD.. The current obv is 120,267,712.

MOREPEN LABORATORIES LTD. Daily On-Balance Volume (OBV) ChartMOREPEN LABORATORIES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MOREPEN LABORATORIES LTD.. The current mfi is 92.68.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
MOREPEN LABORATORIES LTD. Daily Money Flow Index (MFI) ChartMOREPEN LABORATORIES LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MOREPEN LABORATORIES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

MOREPEN LABORATORIES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MOREPEN LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.188
Ma 20Greater thanMa 5079.943
Ma 50Greater thanMa 10081.681
Ma 100Greater thanMa 20078.343
OpenGreater thanClose85.880
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Morepen with someone you think should read this too:
  • Are you bullish or bearish on Morepen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Morepen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MOREPEN LABORATORIES LTD.

I send you an email if I find something interesting about MOREPEN LABORATORIES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about MOREPEN LABORATORIES LTD..

Receive notifications about MOREPEN LABORATORIES LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.